Late-life depression: Detection, risk reduction, and somatic intervention: Commentary on Delano-Wood and Abeles

Clinical Psychology: Science and Practice

Volumn 12, Issue 3, 2005, Pages 218-221

  Sammons, Morgan T ^a  

^a Bureau of Medicine and Surgery   (United States)

Author keywords

Antidepressants; ECT; Late life depression

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; MIRTAZAPINE; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE;

AGED; CARDIOTOXICITY; CLINICAL PROTOCOL; DEPRESSION; DIABETES MELLITUS; DRUG EFFICACY; DYSLIPIDEMIA; ELECTROCONVULSIVE THERAPY; GASTROINTESTINAL HEMORRHAGE; GERIATRIC DEPRESSION SCALE; GERONTOPSYCHIATRY; GROUPS BY AGE; HUMAN; NOTE; ORTHOSTATIC HYPOTENSION; POPULATION RESEARCH; PSYCHOTHERAPY; RISK ASSESSMENT; RISK REDUCTION; SEDATION; SIDE EFFECT; TREATMENT PLANNING; WEIGHT GAIN;

EID: 27144512336     PISSN: 09695893     EISSN: 14682850     Source Type: Journal    
DOI: 10.1093/clipsy/bpi035     Document Type: Note

References (9)

1. Delano-Wood, L., & Abeles, N. (2005). Late-life depression: Detection, risk reduction, and somatic intervention. Clinical Psychology: Science and Practice, 12, 207-217.
2. Food and Drug Administration (2005). FDA public health advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. Retrieved May 1, 2005, from http://www.fda.gov/cder/drug/advisory/ antipsychotics.htm.
3. House, A. O., Hackett, M. L., Anderson, C. S., & Horrocks, J. A. (2005). Pharmaceutical interventions for emotionalism after stroke. The Cochrane Database of Systematic Reviews, 1. Retrieved May 1, 2005, from http://www.cochrane.org
4. Kellner, C. H., Fink, M., Knapp, R., Petrides, G., Husain, M., Rummans, T., et al. (2005). Relief of expressed suicidal intent by ECT: A consortium for research in ECT Study. American Journal of Psychiatry, 162, 977-982.
5. Lenze, L.J., Mulsant, B. H., Shear, M. K., Dew, M. A., Miller, M. D., Pollock, B. G., et al. (2005). Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: Results from an 8-week randomized, placebo-controlled trial. American Journal of Psychiatry, 162, 146-150.
6. National Depressive and Manic Depressive Association. (2000). Beyond diagnosis: A landmark survey of depression and treatment. Chicago: Author.
7. O'Leary, D. A., & Lee, A. S. (1996). Seven-year prognosis in depression. Mortality and readmission risk in the Nottingham ECT cohort. British Journal of Psychiatry, 109, 423-429.
8. Simpson, S., Baldwin, R. C., Jackson, A., & Burns, A. S. (1998). Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological, and neuroradiological findings in late-life depression. Psychological Medicine, 28, 1015-1026.
9. Van der Wurff, F. B., Stek, M. L., Hoogendijk, W. L., & Beekman, A. T. F. (2005). Electro convulsive therapy for the depressed elderly. The Cochrane Database of Systematic Reviews, 1. Retrieved May 1 2005, from http://www.cochrane.org.